Patent Holder

James Piggott

James Piggott
EP0737068B1 2,3-DIARYL-1-BENZOPYRANS FOR TREATING DERMATITIS 
US6268367: Piperazine derivatives for treating bone deficit conditions 

EP0977571A1 PIPERAZINE DERIVATIVES FOR TREATING BONE DEFICIT CONDITIONS 
EP0688214B1 METHODS FOR INHIBITING BONE LOSS WITH 3,4-DIARYLCHROMAN 
US5747059 Atrophy of skin/mucous membrane 
EP0873121A1 USE OF 3,4-DIPHENYL CHROMANS FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PROPHYLAXIS OF ATROPHY OF SKIN AND/OR MUCOUS MEMBRANES
EP0873120A1 USE OF 3,4-DIPHENYL CHROMANS FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PROPHYLAXIS OF MENOPAUSAL SYMPTOMS
WO9725036A1 USE OF 3,4DIPHENYL CHROMANS FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PROPHYLAXIS OF ATROPHY OF SKIN AND/OR MUCOUS MEMBRANES
WO9725035A1 USE OF 3,4DIPHENYL CHROMANS FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PROPHYLAXIS OF MENOPAUSAL SYMPTOMS
US5698521 Native calcitonin mimetics 
US5677334 Method for inhibiting the stimulation of a glucagon-induced response pathway in a warm-blooded animal in need thereof
EP0804190A1 USE OF 3,4-DIPHENYL CHROMANS FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PROPHYLAXIS OF GYNAECOLOGICAL DISORDERS
WO9621444A1 USE OF 3,4-DIPHENYL CHROMANS FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PROPHYLAXIS OF GYNAECOLOGICAL DISORDERS
US5583143 Methods for inhibiting calmodulin activity 
US5552413 Methods for inhibiting hyperproliferation of keratinocytes 
US5510459 Glucagon antagonists 
US5508304 Glucagon antagonists and methods relating thereto 
US5480903 3,4-diarylchromans for inhibiting calmodulin activity 
EP0737068A1 2,3-DIARYL-1-BENZOPYRANS FOR TREATING DERMATITIS 
EP0567562B1 METHODS FOR DETECTING GLUCAGON ANTAGONISTS 
WO9517891A1 2,3-DIARYL-1-BENZOPYRANS FOR TREATING DERMATITIS 
US5464862 Method for inhibiting bone loss using centchroman derivatives 
US5451603 3,4-diarylchromans for treatment of dermatitis 
US5416098 Method for treating dermatitis and related conditions 
US5408037 Methods for detecting glucagon antagonists 
EP0688215A1 3,4-DIARYLCHROMANS FOR TREATMENT OF DERMATITIS 
EP0688214A1 METHODS FOR INHIBITING BONE LOSS WITH 3,4-DIARYLCHROMAN 
EP0658170A1 GLUCAGON ANTAGONISTS AND METHODS FOR DETECTING GLUCAGON ANTAGONISTS 
WO9420099A1 3,4-DIARYLCHROMANS FOR TREATMENT OF DERMATITIS 
WO9420098A1 METHODS FOR INHIBITING BONE LOSS WITH 3,4-DIARYLCHROMAN 
WO9414427A3 USE OF SKYRIN AND ANALOGUES FOR THE TREATMENT OF DIABETES MELLITUS AND PROCESS FOR THEIR 
WO9414427A2 USE OF SKYRIN AND ANALOGUES FOR THE TREATMENT OF DIABETES MELLITUS AND PROCESS FOR THEIR PREPARATION 
WO9405699A1 GLUCAGON ANTAGONISTS AND METHODS FOR DETECTING GLUCAGON ANTAGONISTS 
US5280040 Methods for reducing bone loss using centchroman 
EP0567562A1 METHODS FOR DETECTING GLUCAGON ANTAGONISTS 
 
WO9212998A1 METHODS FOR DETECTING GLUCAGON ANTAGONISTS